Yukinori Yoshimura Selected Research

lingual antimicrobial peptide

9/2016	Change in viable bacterial count during preservation of milk derived from dairy cows with subclinical mastitis and its relationship with antimicrobial components in milk.
2/2015	Dynamics of lingual antimicrobial peptide, lactoferrin concentrations and lactoperoxidase activity in the milk of cows treated for clinical mastitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukinori Yoshimura Research Topics

Disease

6	Infections 01/2018 - 06/2013
3	Bronchitis 04/2022 - 03/2015
3	Mastitis 09/2021 - 02/2015
3	Inflammation (Inflammations) 12/2020 - 01/2018
2	Newcastle Disease 04/2022 - 12/2020
1	Marek Disease (Marek's Disease) 12/2020
1	Virus Diseases (Viral Diseases) 03/2015
1	Neoplasms (Cancer) 02/2013
1	Ovarian Neoplasms (Ovarian Cancer) 02/2013
1	Carcinogenesis 02/2013
1	Body Weight (Weight, Body) 01/2007

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 06/2013
3	CytokinesIBA 01/2018 - 05/2014
2	LipopolysaccharidesIBA 04/2022 - 12/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2021 - 02/2015
2	DefensinsIBA 12/2020 - 04/2015
2	LactoperoxidaseIBA 09/2016 - 02/2015
2	lingual antimicrobial peptideIBA 09/2016 - 02/2015
2	LactoferrinIBA 09/2016 - 02/2015
2	Estrogens (Estrogen)FDA Link 03/2015 - 02/2013
1	VaccinesIBA 04/2022
1	Viral RNAIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Immunologic Factors (Immunomodulators)IBA 02/2015
1	Cefazolin (Ancef)FDA LinkGeneric 02/2015
1	Collagen Type I (Type I Collagen)IBA 05/2014
1	CPG-oligonucleotideIBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	beta-DefensinsIBA 02/2013
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2007

Therapy/Procedure

1	Oral Administration 01/2020
1	Aftercare (After-Treatment) 02/2015
1	Therapeutics 02/2013